Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing

American Journal of Gastroenterology

Volumn 108, Issue 10, 2013, Pages 1601-1611

  Zhang, Zhigang ^a   Zhai, Huiqin ^b   Geng, Jiawei ^b   Yu, Rui ^a   Ren, Haiqing ^a   Fan, Hong ^b   Shi, Peng ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b FIRST PEOPLE S HOSPITAL OF YUNNAN PROVINCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; RIBOSOME DNA; RNA 16S; UREASE;

ACIDAMINOCOCCACEAE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GENE SEQUENCE; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HUMAN; INTESTINE FLORA; LIVER CIRRHOSIS; MALE; MICROBIOME; PRIORITY JOURNAL; PYROSEQUENCING; STREPTOCOCCACEAE; STREPTOCOCCUS SALIVARIUS;

ADULT; AGED; CASE-CONTROL STUDIES; FECES; FEMALE; GASTROINTESTINAL TRACT; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; METAGENOME; MIDDLE AGED; RNA, RIBOSOMAL, 16S; SEVERITY OF ILLNESS INDEX; STREPTOCOCCACEAE; VEILLONELLACEAE;

EID: 84885480599     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.221     Document Type: Article

References (62)

1. Weissenborn K. Minimal hepatic encephalopathy: A permanent source of discussion. Hepatology 2002; 35: 494-6
2. Liu Q, Duan ZP, Ha DK et al. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-9
3. Ferenci P, Lockwood A, Mullen K et al. Hepatic encephalopathy - defi nition, nomenclature, diagnosis, and quantifi cation: Fi nal report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21
4. Montgomery J, Bajaj J. Advances in the evaluation and management of minimal hepatic encephalopathy. Curr Gastroenterol Rep 2011; 13: 26-33
5. Dbouk N, McGuire B. Hepatic encephalopathy: A review of its pathophysiology and treatment. Curr Treat Options Gastroenterol 2006; 9: 464-74
6. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010; 7: 515-25
7. Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy Gut 2008; 57: 1156-65
8. Riordan SM, Williams R. Gut flora and hepatic encephalopathy in patients with cirrhosis. N Engl J Med 2010; 362: 1140-2
9. Sherlock S. Chronic portal systemic encephalopathy: Update 1987. Gut 1987; 28: 1043-8
10. Kumashiro R. Treatment of minimal hepatic encephalopathy. Hepatol Res 2008; 38: S128 - 31
11. Prasad S, Dhiman RK, Duseja A et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59
12. Shukla S, Shukla A, Mehboob S et al. Meta-analysis: The Effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011; 33: 662-71
13. Shawcross DL, Wright G, Olde Damink SWM et al. Role of ammonia and Inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007; 22: 125-38
14. Felipo V, Urios A, Montesinos E et al. Contribution of hyperammonemia and Inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metab Brain Dis 2012; 27: 51-8
15. Bajaj JS, Ridlon JM, Hylemon PB et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 2012; 302: G168 - 75
16. Bajaj JS, Hylemon PB, Ridlon JM et al. Colonic mucosal microbiome diff ers from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and Inflammation. Am J Physiol Gastrointest Liver Physiol 2012; 303: G675 - 85
17. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97
18. Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases Practice Guidelines. Hepatology 2000; 31: 1005-13
19. Chapman R, Fevery J, Kalloo A et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51: 660-78
20. Pugh RNH, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9
21. Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology 2009; 50: 2014-21
22. Li YY, Nie YQ, Sha WH et al. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 2004; 10: 2397-401
23. Luo M, Li L, Yang E - N et al. Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis. Hepatol Res 2012; 42: 1202-10
24. Felipo V, Ordoño JF, Urios A et al. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests. Hepatology 2012; 55: 530-9
25. Bajaj JS, Heuman DM, Wade JB et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011; 140: 478-87. e1
26. Amodio P, Ridola L, Schiff S et al. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 2010; 139: 510-8. e2
27. Bajaj JS, Saeian K, Schubert CM et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test. Hepatology 2009; 50: 1175-83
28. Dhiman RK, Saraswat VA, Verma M et al. Figure connection test: A universal test for assessment of mental state. J Gastroen Hepatol 1995; 10: 14-23
29. Randolph C, Hilsabeck R, Kato A et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29: 629-35
30. Caporaso JG, Kuczynski J, Stombaugh J et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7: 335-6
31. Reeder J, Knight R. Rapidly denoising pyrosequencing amplicon reads by exploiting rank-abundance distributions. Nat Methods 2010; 7: 668-9
32. Li W, Godzik A. Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 2006; 22: 1658-9
33. DeSantis TZ, Hugenholtz P, Larsen N et al. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006; 72: 5069-72
34. Caporaso JG, Bittinger K, Bushman FD et al. PyNAST: A fl exible tool for aligning sequences to a template alignment. Bioinformatics 2010; 26: 266-7
35. Haas BJ, Gevers D, Earl A et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 2011; 21: 494-504
36. Price MN, Dehal PS, Arkin AP. FastTree: Computing large minimum evolution trees with profi les instead of a distance matrix. Mol Biol Evol 2009; 26: 1641-50
37. Eckburg PB, Bik EM, Bernstein CN et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-8
38. Lozupone CA, Hamady M, Kelley ST et al. Quantitative and qualitative diversity measures lead to diff erent insights into factors that structure microbial communities. Appl Environ Microbiol 2007; 73: 1576-85
39. Smoot ME, Ono K, Ruscheinski J et al. Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics 2011; 27: 431-2
40. Assenov Y, Ramírez F, Schelhorn S - E et al. Computing topological parameters of biological networks. Bioinformatics 2008; 24: 282-4
41. Rivera C, Vakil R, Bader J. NeMo: Network module identification in Cytoscape. BMC Bioinformatics 2010; 11: S61
42. Bader G, Hogue C. An automated method for fi nding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003; 4: 2
43. Rani A, Sharma A, Rajagopal R et al. Bacterial diversity analysis of larvae and adult midgut microflora using culture-dependent and cultureindependent methods in lab-reared and field-collected Anopheles stephensi-an Asian malarial vector. BMC Microbiol 2009; 9: 96
44. Shade A, Handelsman J. Beyond the Venn diagram: The hunt for a core microbiome. Environ Microbiol 2012; 14: 4-12
45. Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-80
46. Girvan M, Newman MEJ. Community structure in social and biological networks. Proc Natl Acad Sci USA 2002; 99: 7821-6
47. Newman MEJ. Modularity and community structure in networks. Proc Natl Acad Sci USA 2006; 103: 8577-82
48. Rives AW, Galitski T. Modular organization of cellular networks. Proc Natl Acad Sci USA 2003; 100: 1128-33
49. Pinkert S, Schultz J, Reichardt J. Protein interaction networks - more than mere modules. PLoS Comput Biol 2010; 6: E1000659
50. Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-7
51. Bajaj JS, Heuman DM, Sanyal AJ et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One 2013; 8: E60042
52. Chen Y, Yang F, Lu H et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 2011; 54: 562-72
53. Sonnenburg JL, Xu J, Leip DD et al. Glycan foraging in vivo by an intestineadapted bacterial symbiont. Science 2005; 307: 1955 - 9
54. Mahowald MA, Rey FE, Seedorf H et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA 2009; 106: 5859-64
55. Wu S, Rhee K - J, Albesiano E et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17T cell responses. Nat Med 2009; 15: 1016-22
56. Chen Y - YM, Weaver CA, Burne RA. Dual functions of Streptococcus salivarius urease. J Bacteriol 2000; 182: 4667-9
57. Chen Y - YM, Burne RA. Identification and characterization of the nickel uptake system for urease biogenesis in Streptococcus salivarius 57 .I. J Bacteriol 2003; 185: 6773-9
58. Miquel J, Barcena R, Boixeda D et al. Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy. Eur J Gastroenterol Hepatol 2001; 13: 1067-72
59. Jain L, Sharma BC, Sharma P et al. Serum endotoxin and Inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Digest Liver Dis 2012; 44: 1027-31
60. Shawcross DL, Shabbir SS, Taylor NJ et al. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2010; 51: 1062-9
61. Wright G, Jalan R. Ammonia and Inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? Hepatology 2007; 46: 291-4
62. Guerra-Ruiz A, Casafont F, Cobo M et al. Increased bactericidal/ permeability increasing protein in patients with cirrhosis. Liver Int 2010; 30: 94-101